• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [884 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2008 Agency for Healthcare Research and Quality (AHRQ) Screening and treatment for bacterial vaginosis in pregnancy: systematic review to update the 2001 U.S. Preventive Services Task Force recommendation
2008 NIHR Health Technology Assessment programme Performance of screening tests for child physical abuse in accident and emergency departments
2008 Agency for Healthcare Research and Quality (AHRQ) Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the U.S. Preventive Services Task Force.
2008 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Screening for colorectal cancer: the significance of participation rates - a health technology assessment]
2007 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) HTA of screening for haemoglobinopathia in Aarhus County, Denmark
2007 Haute Autorite de sante (HAS) Assessment of systematic screening for permanent bilateral deafness in neonates
2007 NIHR Health Technology Assessment programme A review and critique of modelling in prioritising and designing screening programmes
2007 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Screening for abdominal aortic aneurysm in high-risk population (HTA report)]
2007 Institute of Health Economics (IHE) Screening newborns for hearing: the use of the automated auditory brainstem response and otoacoustic emissions tests for newborn hearing screening
2007 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Validity and cost-effectiveness of methods for screening of primary open angle glaucoma]
2007 Institute of Health Economics (IHE) Screening newborns for cystic fibrosis
2007 Basque Office for Health Technology Assessment (OSTEBA) [Prenatal screening of down syndrome]
2007 Basque Office for Health Technology Assessment (OSTEBA) [Interval cancers in the early breast cancer detection programme]
2007 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Review on the medical and health economic evidence for an inclusion of colposcopy in primary screening programs for cervical cancer]
2007 NIHR Health Technology Assessment programme Screening for type 2 diabetes: literature review and economic modelling
2007 NIHR Health Technology Assessment programme A systematic review of the routine monitoring of growth in children of primary school age to identify growth-related conditions
2007 Medical Advisory Secretariat (MAS) Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis
2007 Canary Health Service [Systematic review and cost-effectiveness analysis of diabetic retinopathy screening with a 45º non-mydriatic retinograph using images interpreted by ophthalmologists versus family doctors]
2007 NIHR Health Technology Assessment programme Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses
2007 NIHR Health Technology Assessment programme Epidemiological, social, diagnostic, and economic evaluation of population screening for genital chlamydial infection
2007 NIHR Health Technology Assessment programme Current practice, accuracy, effectiveness and cost-effectiveness of the school entry hearing screen
2007 HAYES, Inc. Computer-aided detection for screening mammography
2007 New Zealand Health Technology Assessment (NZHTA) Performance of commercially available HPV tests
2007 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Information to users on cancer screening in women: assessment of current situation and establishment of evidence-based information standards. 1. Information to users on breast cancer screening]
2007 NIHR Health Technology Assessment programme A comparison and discussion of the methods, findings, adaptability and decisions resulting from two reviews of vision screening in children undertaken in the UK and Germany
2007 NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation
2007 NIHR Health Technology Assessment programme Acceptability, benefit and costs of early screening for hearing disability: a study of potential screening tests and models
2007 The Netherlands Organisation for Health Research and Development (ZonMw) [Performance of specialised breast technicians in diagnostic breast imaging]
2007 New Zealand Health Technology Assessment (NZHTA) Effectiveness and cost-effectiveness of population screening for colorectal cancer: a systematic review of the literature (revised edition)
2007 Adelaide Health Technology Assessment (AHTA) Perinatal Hepatitis C screening
2007 Adelaide Health Technology Assessment (AHTA) Opportunistic screening of asymptomatic individuals for Chlamydia
2007 Adelaide Health Technology Assessment (AHTA) OraSure HIV point of care testing
2007 VA Technology Assessment Program (VATAP) Functional imaging screening for traumatic brain injury
2007 Adelaide Health Technology Assessment (AHTA) Ovarian cancer symptom index
2007 HAYES, Inc. Fecal DNA testing for colorectal cancer screening and monitoring
2007 HAYES, Inc. Fetal fibronectin test in asymptomatic women
2007 Medical Services Advisory Committee (MSAC) Hepatitis B DNA testing
2007 The Netherlands Organisation for Health Research and Development (ZonMw) [Implementation of evidence-based guidelines for appropriate use of ultrasonography in diagnostic breast imaging: the MAMMOED-2 study]
2007 University of York Diagnostic accuracy and cost-effectiveness of faecal occult blood tests (FOBT) used in screening for colorectal cancer: a systematic review
2007 Canadian Agency for Drugs and Technologies in Health (CADTH) Preschool vision screening
2007 Agency for Healthcare Research and Quality (AHRQ) Screening for elevated blood lead levels in childhood and pregnancy: Update of a 1996 U.S. preventive services task force review
2007 NIHR Health Technology Assessment programme A study to evaluate the most cost-effective way to screen for Chlamydia trachomatis genital tract infection and reduce its prevalence and associated burden of disease - primary research
2007 Agency for Healthcare Research and Quality (AHRQ) Evidence for the reaffirmation of the U.S. Preventive Services Task Force recommendation on screening for high blood pressure
2007 Agency for Healthcare Research and Quality (AHRQ) Screening for chlamydial infection: a focused evidence update for the U.S. Preventive Services Task Force
2007 Agency for Healthcare Research and Quality (AHRQ) Screening for human immunodeficiency virus: focused update of a 2005 systematic evidence review for the U.S. Preventive Services Task Force
2007 Quality Improvement Scotland (NHS QIS ) The clinical and cost effectiveness of screening for meticillin-resistant Staphylococcus aureus (MRSA)
2007 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Efficacy and effectiveness of screening for abdominal aortic aneurysm in a high risk population. Cost-effectiveness analysis. Applicability in the National Health Care Service]
2007 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry. Systematic Review]
2007 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Mammography screening. Evidence-based evaluation of mammography-based breast cancer screening programmes
2007 Medical Advisory Secretariat (MAS) Optimal health system design for preventive health screening
2007 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Description of cancer screening in Spain. DESCRIC Project
2007 HAYES, Inc. Tandem mass spectrometry for metabolic disease screening of newborns
2007 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Description of the current status of the prenatal screening of the most frequent fetal chromosomal diseases -especially Down's Syndrome- in Spain, and proposals for improvement of everyday clinical practice
2007 Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Tandem mass spectrometry and neonatal blood screening in Quebec]
2007 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Review on the medical and health economic evidence for an inclusion of colposcopy in primary screening programs for cervical cancer]
2007 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Assessment of effectiveness and cost-effectiveness of HPV testing in primary screening for cervical cancer]
2007 Agency for Healthcare Research and Quality (AHRQ) Screening for lipid disorders in children and adolescents:systematic evidence review for the U.S. Preventive Services Task Force
2007 Agency for Healthcare Research and Quality (AHRQ) Screening for hemoglobinopathies in newborns: reaffirmation update for the U.S. Preventive Services Task Force
2007 Agency for Healthcare Research and Quality (AHRQ) Screening for asymptomatic carotid artery stenosis
2006 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Screening of the hearing of newborns - Update
2006 NIHR Health Technology Assessment programme The cost-effectiveness of screening for oral cancer in primary care
2006 NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviews
2006 Belgian Health Care Knowledge Centre (KCE) Screening for colorectal cancer: current evidence and budget impact within Belgium
2006 Agency for Healthcare Research and Quality (AHRQ) Screening for iron deficiency anemia in childhood and pregnancy update of the 1996 U.S. Preventive Task Force review
2006 Medical Advisory Secretariat (MAS) Utilization of DXA bone mineral densitometry in Ontario: an evidence-based analysis
2006 Medical Advisory Secretariat (MAS) Routine eye examinations for persons 20-64 years of age: an evidence-based analysis
2006 Agency for Healthcare Research and Quality (AHRQ) Screening for speech and language delay in preschool children
2006 Belgian Health Care Knowledge Centre (KCE) Prostate-specific-antigen (PSA) for the screening of prostate cancer
2006 Finnish Office for Health Care Technology Assessment (Finohta) The impact of an extension of breast cancer screening: update of Finohta's report 16/2000
2006 New Zealand Health Technology Assessment (NZHTA) Review of the National Cervical Screening programme. Chapter 5: interim operational policy and quality standards 2000. Technical brief.
2006 NIHR Health Technology Assessment programme Computed tomography screening for heart disease
2006 Adelaide Health Technology Assessment (AHTA) Screening for hypertrophic cardiomyopathy in individuals at high-risk of sudden cardiac death
2006 Adelaide Health Technology Assessment (AHTA) Genetic testing for long QT syndrome; horizon scanning prioritising summary - volume 13
2006 Blue Cross Blue Shield Association (BCBS) Screening for vertebral fracture with dual x-ray absorptiometry
2006 Blue Cross Blue Shield Association (BCBS) Full-field digital mammography
2006 Agency for Healthcare Research and Quality (AHRQ) Screening for developmental dysplasia of the hip
2006 Basque Office for Health Technology Assessment (OSTEBA) [Information required for analyzing the impact of the early breast cancer detection programme]
2006 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Clinical and cost-effectiveness of screening newborns for medium chain acyl~CoA dehydrogenase deficiency using tandem mass spectrometry
2006 Basque Office for Health Technology Assessment (OSTEBA) [Incidence of diabetic retinopathy based on a screening programme using a non-mydriatic retinal camera on diabetic patients in the Autonomous Community of the Basque Country]
2006 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Newborn screening for medium chain acyl~CoA cehydrogenase deficiency using tandem mass spectrometry: clinical and cost-effectiveness
2006 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Use and performance of clinical mammography in Denmark]
2006 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) Preventive health screenings and health consultations in primary care - an analysis of the psychosocial impact
2006 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Preventive health screenings and health consultations in primary care]
2006 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Interventions for increasing uptake in screening programmes
2006 New Zealand Health Technology Assessment (NZHTA) Screening strategies for antenatal Down syndrome screening
2006 NIHR Health Technology Assessment programme Evaluation of molecular techniques in prediction and diagnosis of CMV disease in immunocompromised individuals- primary research
2006 Quality Improvement Scotland (NHS QIS ) Screening hips of newborns in Scotland: a Health Technology Assessment scoping report
2006 Agency for Healthcare Research and Quality (AHRQ) Screening for hereditary hemochromatosis
2006 ECRI Immunochemical fecal occult blood test for colorectal cancer screening
2006 Health Council of the Netherlands Gezondheidsraad (GR) Annual report on screening for disease
2006 Belgian Health Care Knowledge Centre (KCE) Cervical cancer screening and Human Papillomavirus (HPV) testing
2006 Blue Cross Blue Shield Association (BCBS) Special report: fecal DNA analysis for colon cancer screening
2006 NIHR Health Technology Assessment programme Evaluation of molecular techniques in prediction and diagnosis of cytomegalovirus disease in immunocompromised patients
2006 NIHR Health Technology Assessment programme Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study
2006 Medical Advisory Secretariat (MAS) Ultrasound screening for abdominal aortic aneurysm: an evidence-based analysis
2006 NIHR Horizon Scanning Centre (NIHR HSC) Computed tomography (CT) screening in risk assessment for coronary artery disease: horizon scanning technology briefing
2006 NIHR Horizon Scanning Centre (NIHR HSC) Computed tomography (CT) angiography for the diagnosis and management of coronary artery disease: horizon scanning technology briefing
2005 NIHR Health Technology Assessment programme A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study
2005 Finnish Office for Health Care Technology Assessment (Finohta) Hearing screening for newborns
2005 Agency for Healthcare Research and Quality (AHRQ) Primary care screening for ocular hypertension and primary open-angle glaucoma: evidence synthesis